Podcast 28 Feb 2025
The TCR-T cell therapies of tomorrow
Sweden’s fastest growing private biotech, Anocca, is making plans for clinical trials in pancreatic cancer, with TCR-T cell therapy trials.
Clinical trial
- Latest Posts
Best in Biotech 25 Feb 2025
Seven biotech spinouts to watch out for in 2025
Here are seven biotech spinouts to keep an eye out for this year that specialize in a number of therapeutic areas.
In Depth 21 Feb 2025
The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Discover how biotech could solve the organ shortage crisis through xenotransplantation, 3D bioprinting and stem cells.
News and Trends 19 Feb 2025
Trade war: how new U.S. tariffs will impact the biopharma industry
The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?
In Depth 18 Feb 2025
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer.
Why the right software is key to efficient trial design
Facing delays and inefficiencies in clinical trial design? Learn how the right software can solve key challenges and improve outcomes.
ADVERTISEMENT
ADVERTISEMENT
In Depth 10 Feb 2025
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies.
In Depth 4 Feb 2025
World Cancer Day: trends in cancer therapeutics to look forward to in 2025
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025.
In Depth 29 Jan 2025
Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic
Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat.
News and Trends 28 Jan 2025
ITM-11 succeeds in phase 3: The first big win for radiopharma?
Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.
Best in Biotech 27 Jan 2025
Top 19 most-performing biotech stocks of 2024
Discover the top-performing biotech stocks in 2024 – from oncology to psychedelics some companies showed remarkable results.
In Depth 23 Jan 2025
mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics
In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases.
ADVERTISEMENT
